Good morning,

I added the first tranche to my portfolio yesterday evening. $CLBT (-0.92%) into the portfolio last night. Target size 250 shares.

LG and have a nice weekend

John

After only a few days of holding the shares, we had to $CLBT (-0.92%) had to leave the depot yesterday.

May was a good month with a return of +6.24%.

The YTD is with +6% finally back in the green. 📈

The winners in May are:

$RKLB (+0.27%) with a plus of almost 83% 📈

$IREN (-2.91%) with a plus of over 46% 📈

$ONDS (-0.93%) with an increase of over 40% 📈

Losers in May are:

$PNG (-2.95%) with a minus of over 2% 📉

$MDB (+0.12%) with a minus of almost 2% 📉

$ASML (-1.85%) with a minus of almost 2% 📉

New stocks found their way into the portfolio:

$MDB (+0.12%) , $ASML (-1.85%) , $SU (-1.23%) , $VSTM (-0.62%)
$CLBT (-0.92%)

Other values had to give way:

$LMND (-0.43%) , $OHB (+1.76%) , $ZTS (+0.72%) , $TEM (-0.97%) , $DR0 (+3.18%) , $MSFT (+0.25%)

A realignment of my strategy is planned from next month. The aim is to build up a core. This is currently still at a portfolio size of just under 54%. $4GLD (-1.25%) . This is to be left behind, instead the $ (-0.41%)VWRL (-0.41%) is to be saved with €20 per day.

In addition, I started my small AI project Velocity. More details on this in the last post.

... The foundation stone for wealth has been laid

Thank you @Get_Rich_or_Die_Tryin & @Aktienhauptmeister for presenting this pearl to us 🙏🏽

FOMO has definitely hooked me, that's why I decided to join here 😁

let's see where the journey goes 👀🚀

The money freed up by the triggered SL of $OHB (+1.76%) has now been partly invested in a new security that I did not know about until yesterday.

Thank you @Get_Rich_or_Die_Tryin for the great presentation!

$CLBT (-0.92%)

@Get_Rich_or_Die_Tryin My dearest, thank you for the introduction. You know my opinion of the company. And we could hardly believe what we discovered for ourselves. The figures, the fundamental data and the prospects speak for themselves! We actually didn't hesitate for long and got in a few days ago 🤝🫶 $CLBT (-0.92%)

*Will probably add a little more in the next few days😏

Hello dear community,

by popular demand, here's something that probably flies under the radar for most people. My friend Rob and I would like to briefly and concisely $CLBT (-0.92%) today. Due to a lack of time, I was admittedly dependent on Rob's support for the presentation, but I can share the information he provided with you with a clear conscience, as I have of course also checked the current figures myself. So, enjoy the show:

Hi there, Rob here, your trusted doorman for clean cash flow. You wanted to take a look at one of the niche kings in the portfolio? Perfect. I have Cellebrite DI (ticker: CLBT). These guys are basically the "CSI" of digital forensics - when the authorities need to crack a locked smartphone, they ring Cellebrite.

It's not hype, it's a tough monopoly business with a guaranteed moat. I have dissected the brand-new figures from the first quarter of 2026 (Q1/26), mirrored them against the expectations of the fine analysts and looked at the news flow.

Here is the unvarnished final boss check for getquin.

☠️ Cellebrite DI (CLBT) - The digital forensics bouncer in check

Cellebrite is not a classic software company. They are the global market leader in Digital Investigative Intelligence. Their tools help police, intelligence agencies and companies to extract, analyze and manage data from digital sources (cell phones, cloud, computers). While the competition is still fiddling with the charging cable, Cellebrite already has the encrypted chat protocols. The business is "sticky" without end: once you've used the software and trained your investigators on it, you won't switch for five euros fifty.

Here is a look into the machine hall based on the latest ACTUAL figures (Q1/2026).

1. financial check & multiples (ACTUAL vs. estimate)

We are not comparing apples with oranges, but the real results with the consensus. And Cellebrite has delivered, but how!

Key figure

Actual value (Q1/26) | analyst estimate | surprise

Turnover

$128.3 million | $127.01 million | +1,02 % 🟢

Non-GAAP EPS

$0,12 | $0,06 | +100 % 🚀

Adjusted EBITDA

$30.6 million | not explicitly shown

Rob's conclusion: A double EPS beat? Now that's what I call an admission check! Sales grew by 19 % compared to the same quarter last year. That's no coincidence, that's operational excellence. The share price responded with a huge jump.

2. profit flow chart (Q1/2026)

To help you understand how the cash flow machine works, I have created a Sankey diagram. It shows how turnover (top line) becomes net profit (bottom line) at the end.

(Sankey diagram: Revenue and expense flow of Cellebrite DI in Q1 2026. Values in USD million. Data basis: Official quarterly report Q1 2026, non-GAAP figures for COGS/margins to better represent the operating business).

The chart shows it clearly: almost 92% of revenue comes in via subscriptions (subscription revenue). That is predictable, sticky cash flow. With a gross margin of over 82% (GAAP), there is a lot left over to finance R&D, sales and administration before it flows into net profit.

3. future outlook (analyst consensus)

Cellebrite is not only growing, they are scaling. Here is what the market expects for the current and next two financial years.

• FY 2026: Revenue is guided to increase to around $565-571m. Consensus EPS is expected to be around $0.57.

• FY 2027 & FY 2028: Analysts expect average sales growth of approx. 15% p.a. and EPS growth of over 17% p.a.

Rob's conclusion: They easily crack the Rule-of-40 (growth + margin). The free cash flow monster continues to grow.

4. moat, newsflow & dirt on the ground

Moat: Brachial. World market leader with network effects (the more authorities use it, the more standardized the evidence becomes). High switching costs and technological hurdles. Regulatory barriers to entry. Court-proof chains of evidence. Decades of relationships with authorities.

• Newsflow: Very positive. Q1/26 brought an "ARR acceleration" (Annual Recurring Revenue), the net retention rate is 115% (customers are spending more money). New AI products such as "Guardian Investigate" and "Genesis" are very well received.

• Risks: Government clients are a cluster risk (budget dependency). There are always regulatory risks when it comes to data protection. And the competition never sleeps, even if it is miles behind.

Final boss conclusion: Rob's verdict

Cellebrite DI is not a "value trap" capital guzzler. This thing is a highly profitable cash flow machine with a real monopoly moat in a structural growth market. Q1 2026 was a bull's eye, guidance is solid, and the long-term outlook is excellent. The Rule-of-40 is being pulverized.

We don't buy a story, we buy countable and measurable cash flow. Cellebrite delivers. If you are looking for quality and are willing to bear the currency risk (USD/Nasdaq), this digital forensics bouncer is hard to pass up.

My own conclusion for you in bullet points:

- 85%+ software gross margin

- 32 % TTM free cash flow margin

- 115 % net revenue retention

- Over 90 % recurring revenue

- No net debt

- massive expansion of the AI platform "Genesis" = investigative authorities can automatically analyze huge amounts of data - including chats, images, drone forensics and cloud data

- Recently received FedRAMP High certification in the USA. Access to FBI, DOJ and other federal agencies.

For the sake of completeness:

Risks:

- Race against smartphone encryption

- Political discussions around surveillance technology

- Exposure to Israel as an R&D location

In my view, the figures speak for themselves. If you have any questions, let me know in the comments! A small note: I am invested myself.😉

@Aktienhauptmeister
@Tenbagger2024
@Raketentoni and everyone else, of course.

Hello to the GQ community ✌️

My first post after being kicked about 4 weeks ago - who would have thought that solidarity towards one of the members (@Klein-Anleger ) would lead to a ban so quickly? But the goodwill of getquin was so BIG (and above all "on trial") that they graciously let me back into the holy grail of the GQ community 😉

So guys, learn from my mistakes: the goodwill here is not an Infinite Money glitch ! Save your solidarity, reduce your commitment to other members to zero and the most important thing 🚨: No surreptitious advertising for alternative financial platforms like "Cisdord" 😉😂.

Sorry, the side blow after 4 weeks of abstinence had to be 🤝

so joking aside...

⏳The first three months of 2026 have passed. Time for a brief interim summary of the current status of my reconstruction.

Before I started rebuilding the portfolio, I naturally thought about what strategy I wanted to pursue in the coming months and years - especially with regard to stock selection and weighting.

To be honest, my original plan was to keep a portfolio with a maximum of 20 shares. In the course of time, however, I realized that it will probably not stay at 20 stocks, but that the number is more likely to increase to around 30 positions (+/-).

♟️Mein Focus & my strategy:

In a nutshell: The clear focus is on growth 🚀. Dividends tend to play a subordinate role. Here I show you my shopping list and what my portfolio should look like in the future. The stocks I have already bought are marked with a green tick and without a tick, I'm still waiting ⏳

🤖TECH:

• AMAZON $AMZN (+0.05%) ✅
• MICROSOFT $MSFT (+0.25%) ✅
• CROWDSTRIKE $CRWD (-0.29%) ✅
• SYNOPSYS $SNPS (-0.19%) ✅
• INTUIT $INTU (-0.34%) ✅
• CONSTELLATION SOFTWARE $CSU (+0.77%) ✅
• SERVICENOW $NOW (+1.63%) ✅
• ALPHABET $GOOGL (-0.17%)
• NVIDIA $NVDA (-0.65%)
• ASML $ASML (-1.85%)
• MONOLITHIC POWER SYSTEMS $MPWR (+0.59%)
• ARISTA NETWORKS $ANET (+1.04%)
• KEYENCE $6861 (-1.33%) ✅
• TSMC $TSM (+0.62%)
• MARUWA $5344 (+3%)
• LASERTEC CORP $6920 (-4.76%)
• NETCOMPANY $NETC (-0.91%) ✅
• CELLEBRITE DI $CLBT (-0.92%) ✅

🏦💸FINANCE:

• SOFI TECHNOLGIES $SOFI (-1.71%) ✅
• S&P GLOBAL $SPGI (+0.31%) ✅
• VISA $V (-0.14%) ✅
• MUNICH RE $MUV2 (+1.28%) ✅
• GERMAN EXCHANGE $DB1 (+0.23%) ✅
• PARTNERS GROUP $PGHN (-3.35%) ✅
• BROOKFIELD CORP $BN (-0.63%) ✅
• HOULIHAN LOKEY $HLI (-0.16%) ✅
• BROADRIDGE $BR (-0.17%) ✅
• CBOE GLOBAL MARKETS $CBOE (+0.73%)

🏥🩻HEALTHCARE:

• NOVO NORDISK $NOVO B (+3.34%) ✅
• INTUITIVE SURGICAL $ISRG (-0.07%)
• STRYKER $SYK (+0.88%)
• BOSTON $BSX (+0.66%)
• CATALYST PHARM $CPRX (-0.37%)

🏭🏗️INDUSTRIE & REST:

• WASTE MANAGEMENT $WM (-0.53%) ✅
• GRAB HOLDINGS $GRAB (-0.22%) ✅
• CINTAS $CTAS (-0.11%) ✅
• MonotaRO $3064 ✅
• ITOCHU $8001 (+0%) ✅
• HERMES $RMS (-2.17%) ✅
• MERCADOLIBRE $MELI (-0.08%) ✅

------------------------

this is my extended watchlist:

IN TECH:

RAMBUS $RMBS (-0.14%) , QNITY ELECTRONICS $Q (+2.36%) ,

INNODATA $INOD (-0.18%) , NETFLIX $NFLX (+1.81%) ,

VERTIV $VRT (+1.29%) , PALANTIR $PLTR (-0.51%) , VAT GROUP $VACN (-2.08%) , BROADCOM $AVGO (-0.08%) , AMADEUS IT $AMS (-0.87%) , DISCO CORP $6146 (-5.51%) , A10 NETWORKS $ATEN (+0.7%) , RORZE $6323 , CAMTEK $CAMT (-0.22%)

FINANCE:

APOLLO GLOBAL $APO (-0.25%) / BLACKSTONE $BX (-0.46%) , ALLIANZ $ALV (+0.15%) , FIRSTCASH $FCFS (+0.86%) , BLACKROCK $BLK (-0.12%) SKYWARD SPECIALITY INSURANCE $SKWD , VERISK ANALYTICS $VRSK (-0.33%) PRIMERICA $PRI (+0%) , ERIE INDEMNITY $ERIE (+0%)

HEALTHCARE:

MERIT MEDICAL SYSTEMS $MMSI (+0.43%) , REGENERON PHARM $REGN (-0.39%) , UFP TECHNOLOGIES $UFPT (-0.24%) , COLLEGIUM PHARM $COLL (-0.34%) , LIGAND PHARM $LGND (+0%) , HOYA CORP $7741 (-3.9%) , SHIONOGI $4507 (-2.75%) , IRADIMED $IRMD (-0.31%)

REST:

MISUMI GROUP $9962 (-1.42%) , KANEMATSU $8020 (+0.45%) , APPLIED INDUSTRIAL TECH $AIT (-0.2%) , BADGER METER $BMI (-0.17%) , CEMENT ROADSTONE HOLDING $CRH (+1.63%) , KADANT $KAI (+0.38%) , INTERTEK GROUP $ITRK (+0.37%) , IDEX CORP $IEX (-0.2%) , ORLA MINING $OLA (-1.48%) , NEWMARKET CORP $NEU (+0%) , ROTORK $ROR (-1.36%) , POWER INTEGRATION $POWI (-4.12%) , LINDE $LIN (-0.81%) , GAZTRANSPORT & TECHNIGAZ $GTT (-1.54%)

This is not yet my final stock selection/watchlist. Of course, there can always be changes if, for example, the @Tenbagger2024 continues to present such undiscovered gems 🙏🏽🧐

------------------------

What should the sector/country weighting look like?

Let's start with the "desired"

🌍country weighting:

🇺🇸🇨🇦USA ~60%

🇪🇺EUROPA ~20%

🇯🇵JAPAN/ASIA ~15%

Rest ~5%

Sector weighting should be as follows:

💻TECHNOLOGY: ~30-35%

💸FINANCE: ~ 20-25%

HEALTHCARE: ~ 10-15%

🏭INDUSTRY: ~ 10-15%

REST: ~ 5-10%

So, what has happened since the beginning of the year?

Of course there were no sales 😬

There have been a few purchases where I have a finger in the pie.

JANUARY PURCHASES

$INTU (-0.34%)
$GRAB (-0.22%)
$NOW (+1.63%)
$MSFT (+0.25%)

FEBRUARY PURCHASES

$NOW (+1.63%)
$INTU (-0.34%)
$SPGI (+0.31%)
$SNPS (-0.19%)
$CSU (+0.77%)
$SOFI (-1.71%)
$CRWD (-0.29%)

MARCH PURCHASES

$MUV2 (+1.28%)
$3064
$8001 (+0%)
$6861 (-1.33%)
$DB1 (+0.23%)
$V (-0.14%)
$HLI (-0.16%)
$MSFT (+0.25%)
$CTAS (-0.11%)
$MELI (-0.08%)
$BN (-0.63%)
$PGHN (-3.35%)
$BR (-0.17%)

Due to the global political situation - especially because of this 🍊 in the White House, whose tweets cause more tsunamis 🌊than real natural disasters - and the current drawdown in the S&P 500 (which is very convenient for me right now and gives me a lot of pleasure 🤩), I am accordingly under water💦🫧 with some of my purchases so far.

but hey, we're investing for the long term, aren't we? So easy going, all relaxed 🥱 I will most likely not make any more purchases in the next few days or weeks, park my cash position elsewhere or put it in overnight money and wait and see which zone the market settles in or wait for it to stabilize.

What do you have on your watchlist?

Are you currently waiting or how are you dealing with the current situation?

@Get_Rich_or_Die_Tryin
@Tenbagger2024
@Max095 and of course all other members

Ok, that's enough now 😂

that's it from me for now ✌️

your stock master